Melatonin suppresses nitric oxide production in glial cultures by pro-inflammatory cytokines through p38 MAPK inhibition

Free Radical Research

Volumn 48, Issue 2, 2014, Pages 119-128

  Vilar, A ^a   De Lemos, L ^a   Patraca, I ^b   Martinez N ^b   Folch, J ^b   Junyent, F ^a,b   Verdaguer, E ^a   Pallas M ^a   Auladell, C ^a   Camins, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Glial cells; Inflammation; Melatonin; Nitric oxide

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GLIA CELL; GLIAL CELL CULTURE; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; GUANYLATE CYCLASE; INFLAMMATION MEDIATORS; MAP KINASE SIGNALING SYSTEM; MELATONIN; MICE; MICE, INBRED C57BL; NEUROGLIA; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84890082542     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.845295     Document Type: Article

References (43)

1. Khandelwal PJ, Herman AM, Moussa CE. Infl ammation in the early stages of neurodegenerative pathology. J Neuroimmunol 2011; 238: 1-11.
2. Smith JA, Das A, Ray SK, Banik NL. Role of pro-infl ammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 2012; 87: 10-20.
3. Di Stefano A, Iannitelli A, Laserra S, Sozio P. Drug delivery strategies for Alzheimers disease treatment. Expert Opin Drug Deliv 2011; 8: 581-603.
4. Rubio-Perez JM, Morillas-Ruiz JM. A review: Infl ammatory process in Alzheimers disease, role of cytokines. Scientifi c WorldJournal 2012; 75: 63-57.
5. Suzumura A, Takeuchi H, Zhang G, Kuno R, Mizuno T. Roles of glia-derived cytokines on neuronal degeneration and regeneration. Ann N Y Acad Sci 2006; 1088: 219-229.
6. Brown GC. Mechanisms of infl ammatory neurodegeneration: Inos and nadph oxidase. Biochem Soc Trans 2007; 35: 1119-1121.
7. Brown GC. Nitric oxide and neuronal death. Nitric Oxide 2010; 23: 153-165.
8. Chen M, Sun HY, Li SJ, Das M, Kong JM, Gao TM. Nitric oxide as an upstream signal of p38 mediates hypoxia/ reoxygenation-induced neuronal death. Neurosignals 2009; 17: 162-168.
9. Saha RN, Pahan K. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem Int 2006; 49: 154-163.
10. Saha RN, Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 2006; 8: 929-947.
11. Bhat NR, Zhang P, Lee JC, Hogan EL. Extracellular signalregulated kinase and p38 subgroups of mitogen-Activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-Alpha gene expression in endotoxinstimulated primary glial cultures. J Neurosci 1998; 18: 1633-1641.
12. Brown GC, Neher JJ. Infl ammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 2010; 41: 242-247.
13. Kaminska B, Gozdz A, Zawadzka M, Ellert-Miklaszewska A, Lipko M. Mapk signal transduction underlying brain infl ammation and gliosis as therapeutic target. Anat Rec (Hoboken) 2009; 292: 1902-1913.
14. Sastre M, Klockgether T, Heneka MT. Contribution of infl ammatory processes to Alzheimers disease: Molecular mechanisms. Int J Dev Neurosci 2006; 24: 167-176.
15. Sheng W, Zong Y, Mohammad A, Ajit D, Cui J, Han D, et al. Pro-infl ammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of erk1/2, inos and spla(2)-iia expression in astrocytes and microglia. J Neuroinfl ammation 2011; 8: 121.
16. Bachstetter AD, Van Eldik LJ. The p38 map kinase family as regulators of proinfl ammatory cytokine production in degenerative diseases of the CNS. Aging Dis 2010; 1: 199-211.
17. Ji RR, Suter MR. P38 mapk, microglial signaling, and neuropathic pain. Mol Pain 2007; 3: 33.
18. Kyriakis JM, Avruch J. Mammalian mapk signal transduction pathways activated by stress and infl ammation: A 10-year update. Physiol Rev 2012; 92: 689-737.
19. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 2004; 47: 263-274.
20. Bondy SC, Li H, Zhou J, Wu M, Bailey JA, Lahiri DK. Melatonin alters age-related changes in transcription factors and kinase activation. Neurochem Res 2010; 35: 2035-2042.
21. Borah A, Mohanakumar KP. Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents. J Pineal Res 2009; 47: 293-300.
22. Carpentieri A, Diaz de Barboza G, Areco V, Peralta Lopez M, Tolosa de Talamoni N. New perspectives in melatonin uses. Pharmacol Res 2012; 65: 437-444.
23. Chung SY, Han SH. Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J Pineal Res 2003; 34: 95-102.
24. Feng Z, Zhang JT. Protective effect of melatonin on beta-Amyloid-induced apoptosis in rat astroglioma c6 cells and its mechanism. Free Radic Biol Med 2004; 37: 1790-1801.
25. Ionov M, Burchell V, Klajnert B, Bryszewska M, Abramov AY. Mechanism of neuroprotection of melatonin against betaamyloid neurotoxicity. Neuroscience 2011; 180: 229-237.
26. Jeong JK, Moon MH, Lee YJ, Seol JW, Park SY. Melatonininduced autophagy protects against human prion proteinmediated neurotoxicity. J Pineal Res 2012; 53: 138-146.
27. Bhat NR, Feinstein DL, Shen Q, Bhat AN. P38 mapk-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa b, camp response element-binding protein, ccaat/enhancerbinding protein-beta, and activating transcription factor-2. J Biol Chem 2002; 277: 29584-29592.
28. Bhat NR, Zhang P, Bhat AN. Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: Role of p38 mitogen-Activated protein kinase activation. J Neurochem 1999; 72: 472-478.
29. Verkhratsky A. Physiology of neuronal-glial networking. Neurochem Int 2010; 57: 332-343.
30. Verkhratsky A, KirchHoffF. Glutamate-mediated neuronalglial transmission. J Anat 2007; 210: 651-660.
31. Graeber MB, Li W, Rodriguez ML. Role of microglia in cns infl ammation. FEBS Lett 2011; 585: 3798-3805.
32. Lee IC, Kim SH, Lee SM, Baek HS, Moon C, Park SC, et al. Melatonin attenuates gentamicin-induced nephrotoxicity and oxidative stress in rats. Arch Toxicol 2012; 86: 1527-1536.
33. Niranjan R, Nath C, Shukla R. The mechanism of action of MPTP-induced neuroinfl ammation and its modulation by melatonin in rat astrocytoma cells, c6. Free Radic Res 2010; 44: 1304-1316.
34. Camacho ME, Carrion MD, Lopez-Cara LC, Entrena A, Gallo MA, Espinosa A, et al. Melatonin synthetic analogs as nitric oxide synthase inhibitors. Mini Rev Med Chem 2012; 12: 600-617.
35. Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuna-Castroviejo D, Guerrero JM. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996; 20: 205-210.
36. Tocharus J, Chongthammakun S, Govitrapong P. Melatonin inhibits amphetamine-induced nitric oxide synthase mrna overexpression in microglial cell lines. Neurosci Lett 2008; 439: 134-137.
37. Chang KH, de Pablo Y, Lee HP, Lee HG, Smith MA, Shah K. Cdk5 is a major regulator of p38 cascade: Relevance to neurotoxicity in Alzheimers disease. J Neurochem 2010; 113: 1221-1229.
38. Ashabi G, Ramin M, Azizi P, Taslimi Z, Alamdary SZ, Haghparast A, et al. Erk and p38 inhibitors attenuate memory defi cits and increase creb phosphorylation and pgc-1alpha levels in abeta-injected rats. Behav Brain Res 2012; 232: 165-173.
39. Parmentier-Batteur S, Bohme GA, Lerouet D, Zhou-Ding L, Beray V, Margaill I, Plotkine M. Antisense oligodeoxynucleotide to inducible nitric oxide synthase protects against transient focal cerebral ischemia-induced brain injury. J Cereb Blood Flow Metab 2001; 21: 15-21.
40. Tapias V, Escames G, Lopez LC, Lopez A, Camacho E, Carrion MD, et al. Melatonin and its brain metabolite n(1)-Acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice. J Neurosci Res 2009; 87: 3002-3010.
41. Niranjan R, Nath C, Shukla R. Melatonin attenuated mediators of neuroinfl ammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat astrocytoma cells, C6. Free Radic Res 2012; 46: 1167-1177.
42. Xia MZ, Liang YL, Wang H, Chen X, Huang YY, Zhang ZH, et al. Melatonin modulates TLR4-mediated infl ammatory genes through MyD88- And TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells. J Pineal Res 2012; 53: 325-334.
43. Min KJ, Jang JH, Kwon TK. Inhibitory effects of melatonin on the lipopolysaccharide-induced CC chemokine expression in BV2 murine microglial cells are mediated by suppression of B and STAT/GAS activity. J Pineal Res 2012; 52: 296-304. Akt-induced NF-